Agilent Technologies Inc (A) Stake Lowered by Guggenheim Capital LLC

Guggenheim Capital LLC lessened its position in Agilent Technologies Inc (NYSE:A) by 4.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,125,665 shares of the medical research company’s stock after selling 48,238 shares during the period. Guggenheim Capital LLC’s holdings in Agilent Technologies were worth $75,306,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Agilent Technologies by 10.8% in the 1st quarter. BlackRock Inc. now owns 28,445,160 shares of the medical research company’s stock valued at $1,902,983,000 after purchasing an additional 2,779,802 shares in the last quarter. OppenheimerFunds Inc. raised its holdings in shares of Agilent Technologies by 73.5% in the first quarter. OppenheimerFunds Inc. now owns 4,656,405 shares of the medical research company’s stock valued at $311,514,000 after buying an additional 1,973,089 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Agilent Technologies by 3.6% in the fourth quarter. Geode Capital Management LLC now owns 3,606,150 shares of the medical research company’s stock valued at $241,031,000 after buying an additional 126,469 shares during the last quarter. Wells Fargo & Company MN raised its holdings in shares of Agilent Technologies by 21.2% in the first quarter. Wells Fargo & Company MN now owns 2,800,486 shares of the medical research company’s stock valued at $187,353,000 after buying an additional 489,288 shares during the last quarter. Finally, Millennium Management LLC raised its holdings in shares of Agilent Technologies by 21.5% in the fourth quarter. Millennium Management LLC now owns 2,550,899 shares of the medical research company’s stock valued at $170,834,000 after buying an additional 450,925 shares during the last quarter.

Shares of NYSE:A opened at $66.26 on Thursday. The stock has a market cap of $21.16 billion, a price-to-earnings ratio of 28.08, a PEG ratio of 2.31 and a beta of 1.28. Agilent Technologies Inc has a 1-year low of $58.22 and a 1-year high of $75.00. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.32 and a quick ratio of 2.88.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, May 14th. The medical research company reported $0.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.01. The firm had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.21 billion. Agilent Technologies had a return on equity of 18.01% and a net margin of 5.02%. The company’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.58 EPS. sell-side analysts expect that Agilent Technologies Inc will post 2.67 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 25th. Shareholders of record on Tuesday, July 3rd will be issued a dividend of $0.149 per share. The ex-dividend date is Monday, July 2nd. This represents a $0.60 annualized dividend and a yield of 0.90%. Agilent Technologies’s dividend payout ratio is currently 25.42%.

A has been the subject of a number of research analyst reports. Cowen raised Agilent Technologies from a “market perform” rating to an “outperform” rating in a report on Tuesday, May 15th. Morgan Stanley cut their price target on Agilent Technologies from $95.00 to $91.00 and set an “overweight” rating for the company in a report on Wednesday, April 11th. Goldman Sachs Group raised Agilent Technologies from a “neutral” rating to a “buy” rating in a report on Monday, April 9th. ValuEngine raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Finally, JPMorgan Chase & Co. lifted their price target on Agilent Technologies from $75.00 to $80.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Agilent Technologies currently has a consensus rating of “Buy” and an average target price of $72.75.

In other news, Director Boon Hwee Koh sold 6,931 shares of the company’s stock in a transaction dated Tuesday, June 12th. The stock was sold at an average price of $66.38, for a total value of $460,079.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patrick Kaltenbach sold 4,000 shares of the company’s stock in a transaction dated Thursday, March 29th. The shares were sold at an average price of $67.28, for a total value of $269,120.00. Following the completion of the sale, the insider now directly owns 72,547 shares of the company’s stock, valued at $4,880,962.16. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,931 shares of company stock valued at $1,069,650.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit